NPI Details
DR. Paul M Vella, M.D. is an internal medicine in Glastonbury, CT with 38 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Paul M Vella, M.D. NPI is 1447263546. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
969 HEBRON AVE
GLASTONBURY, CT
ZIP 06033-417
Phone: (860) 633-1131
Fax: (860) 633-1636
The NPI 1447263546 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Hemoglobin a1c level (HCPCS:83036)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Urine microalbumin (protein) level (HCPCS:82043)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Liver enzyme (sgpt), level (HCPCS:84460)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- X-ray of chest, 2 views (HCPCS:71046)
- Fee covid-19 vac 13 res (HCPCS:0124A)
- Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
- Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
- Folic acid level, serum (HCPCS:82746)
- Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
- Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
- Hepatitis c antibody screening, for individual at high risk and other covered indication(s) (HCPCS:G0472)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
- Ferritin (blood protein) level (HCPCS:82728)
The enumeration date for this NPI number is 8/13/2006 and was last updated on 7/8/2007.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 031061 | CONNECTICUT | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | E58711 | MEDICARE UPIN | CONNECTICUT | |
